Final programme
COMPARATIVE PHYSIOPATHOLOGY - species differences, do they matter?
10am/5pm
Choice of animal species for regulatory toxicology in pharmaceutical development
Jayne Harris, AstraZeneca
Use of preclinical species to inform human pharmacokinetics in drug development
Christina Chan, AstraZeneca
The immune system: friend or foe in model selection?
Richard Haworth, RosettaPath
Target organ toxicity in non-clinical toxicology studies: Urinary system and Eye - relevance to humans?
Naylor Stuart, Charles River Laboratories
Target organ toxicity in non-clinical toxicology studies; relevance to humans?
Jacobsen Matthew, AstraZeneca